The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty

Area of Science:

• Orthopedics
• Vascular Surgery
• Preventative Medicine

Background:

• Venous thromboembolic disease (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant risk following lower extremity orthopedic surgery.
• Studies indicate high prevalence rates of DVT (41-85%) and PE (0.9-28%) in patients undergoing total joint arthroplasty without thromboprophylaxis.
• The increasing number of total joint arthroplasties necessitates a focus on effective VTE prevention strategies.

Purpose of the Study:

• To review the evidence-based recommendations for VTE prophylaxis in total hip and total knee arthroplasty.
• To discuss the rationale behind pharmacologic and mechanical methods for preventing venous thromboembolism.
• To highlight the importance of appropriate thromboprophylaxis in the context of rising arthroplasty rates.

Main Methods:

• Review of guidelines from the American College of Chest Physicians.
• Synthesis of evidence regarding pharmacologic and nonpharmacologic VTE prevention methods.
• Discussion of historical prevalence data for DVT and PE in orthopedic surgery patients.

Main Results:

• Established high prevalence of DVT and PE in untreated orthopedic surgery patients.
• Identification of pharmacologic and mechanical interventions as key VTE prevention strategies.
• Guidelines provide evidence-based recommendations for prophylaxis in total hip and total knee arthroplasty.

Conclusions:

• Thromboprophylaxis is crucial for patients undergoing total joint arthroplasty to prevent VTE.
• Pharmacologic and mechanical methods offer effective strategies for VTE prevention.
• Adherence to evidence-based guidelines is essential for optimizing patient outcomes after orthopedic surgery.